Dr. Joseph William Flanagan, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 840 Hanshaw Rd, Ithaca, NY 14850 Phone: 607-257-6563 |
Dr. Elliot Rubinstein, M.D. Allergy & Immunology - Allergy Medicare: Not Enrolled in Medicare Practice Location: 840 Hanshaw Road, Asthma & Allergy Associates P.c., Ithaca, NY 14850 Phone: 607-257-6563 |
Dr. Rizwan Khan, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 840 Hanshaw Rd, Ithaca, NY 14850 Phone: 607-257-6563 |
Julie Dk Mcnairn, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 840 Hanshaw Rd, Ithaca, NY 14850 Phone: 607-257-6563 Fax: 607-257-1420 |
News Archive
CTI BioPharma Corp. today announced findings from an investigator-sponsored Phase 2 trial in patients with either primary (de novo) acute myeloid leukemia (AML) or AML that has evolved from myelodysplastic syndrome (MDS). Results showed the combination of tosedostat with low dose cytarabine/Ara-C (LDAC) resulted in an overall response rate (ORR) of 54 percent in elderly patients with AML – with 45 percent of patients achieving durable complete responses (CR).
How can college students draw upon their own strengths, resilience, and sense of social connectedness to help them maintain mental health and wellness? Researchers, students and U-M community members will discuss this question at the annual Depression on College Campuses Conference, held March 7-8. The conference - which is marking its 10th anniversary - features workshops and sessions focused on reframing the discussion about mental health on college campuses by emphasizing the importance of student strengths in preventing depression.
New research from the University of Warwick and the IZA Institute in Bonn shows that 10% of middle-aged Europeans took antidepressants in 2010. The researchers looked in detail at the lives of a randomly selected sample of nearly 30,000 Europeans. The study covered 27 countries.
A research team at the University of Colorado Cancer Center has identified an enzyme that could be used to diagnose colon cancer earlier. It is possible that this enzyme also could be a key to stopping the cancer.
› Verified 4 days ago